Therapeutics, Inc.
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1997-01-01
- Employees
- 51
- Market Cap
- -
A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis
- Conditions
- Plaque Psoriasis
- Interventions
- Drug: 122-0551 FoamDrug: Vehicle Foam
- First Posted Date
- 2015-02-20
- Last Posted Date
- 2018-11-08
- Lead Sponsor
- Therapeutics, Inc.
- Target Recruit Count
- 144
- Registration Number
- NCT02367911
- Locations
- 🇺🇸
Total Skin and Beauty Dermatology Center, PC, Birmingham, Alabama, United States
🇺🇸UCSD Dermatology, San Diego, California, United States
🇺🇸Leavitt Medical Associates of Florida d/b/a Ameriderm Research, Ormond Beach, Florida, United States
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305)
- Conditions
- Plaque Psoriasis
- Interventions
- Drug: 000-0551 LotionDrug: Vehicle Lotion
- First Posted Date
- 2013-06-20
- Last Posted Date
- 2017-02-13
- Lead Sponsor
- Therapeutics, Inc.
- Target Recruit Count
- 222
- Registration Number
- NCT01882647
- Locations
- 🇺🇸
Park Avenue Dermatology, PA, Orange Park, Florida, United States
🇺🇸Florida Academic Dermatology Center, Miami, Florida, United States
🇺🇸The Indiana Clinical Trials Center, PC, Plainfield, Indiana, United States
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
- Conditions
- Plaque Psoriasis
- Interventions
- Drug: 000-0551 LotionDrug: Vehicle Lotion
- First Posted Date
- 2013-06-06
- Last Posted Date
- 2016-05-13
- Lead Sponsor
- Therapeutics, Inc.
- Target Recruit Count
- 221
- Registration Number
- NCT01871402
- Locations
- 🇺🇸
Oregon Medical Research Center, PC, Portland, Oregon, United States
🇺🇸Wilmington Dermatology Center, Wilmington, North Carolina, United States
🇺🇸UCSD Dermatology, San Diego, California, United States
A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis
- Conditions
- PsoriasisPlaque Psoriasis
- Interventions
- Drug: VehicleDrug: 122-0551
- First Posted Date
- 2012-10-04
- Last Posted Date
- 2018-10-25
- Lead Sponsor
- Therapeutics, Inc.
- Target Recruit Count
- 44
- Registration Number
- NCT01700985
- Locations
- 🇺🇸
Therapeutics Clinical Research, San Diego, California, United States
🇺🇸DermResearch, Inc., Austin, Texas, United States
Pharmacokinetics of 122-0551 and Its Effects on Adrenal Suppression
- Conditions
- Plaque Psoriasis
- Interventions
- Drug: 122-0551
- First Posted Date
- 2012-10-03
- Last Posted Date
- 2018-10-24
- Lead Sponsor
- Therapeutics, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT01698333
- Locations
- 🇺🇸
Anaheim Clinical Trials, Anaheim, California, United States
🇺🇸DermResearch, Inc., Austin, Texas, United States
🇺🇸Therapeutics Clinical Research, San Diego, California, United States
A Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis
- Conditions
- PsoriasisPlaque Psoriasis
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-06-04
- Last Posted Date
- 2016-05-13
- Lead Sponsor
- Therapeutics, Inc.
- Target Recruit Count
- 72
- Registration Number
- NCT01610596
- Locations
- 🇺🇸
Minnesota Clinical Study Center, Fridley, Minnesota, United States
🇺🇸DermResearch, Inc., Austin, Texas, United States
🇺🇸Therapeutics Clinical Research, San Diego, California, United States
Blinded Study of Topical Investigational Lotion Vs. Approved Cream in Treatment of Plaque Psoriasis
- Conditions
- Plaque Psoriasis
- Interventions
- First Posted Date
- 2010-07-21
- Last Posted Date
- 2016-05-16
- Lead Sponsor
- Therapeutics, Inc.
- Target Recruit Count
- 43
- Registration Number
- NCT01166646
- Locations
- 🇺🇸
DermResearch Inc., Austin, Texas, United States
🇺🇸Michigan Center for Skin Care Research (dba Skin Care Research), Clinton Township, Michigan, United States
🇺🇸Somerset Skin Centre, Troy, Michigan, United States